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Diffusion in cell membranes is not just simple two-dimensional Brownian motion, but typically
depends on the timescale of the observation. The physical origins of this anomalous sub-diffusion
are unresolved, and model systems capable of quantitative and reproducible control of membrane
diffusion have been recognized as a key experimental bottleneck. Here we control anomalous dif-
fusion using supported lipids bilayers containing lipids derivatized with polyethylene glycol (PEG)
headgroups. Bilayers with specific excluded area fractions are formed by control of PEG-lipid mole
fraction. These bilayers exhibit a switch in diffusive behavior, becoming anomalous as bilayer con-
tinuity is disrupted. Diffusion in these bilayers is well-described by a power-law dependence of
the mean square displacement with observation time. The parameters describing this diffusion can
be tailored by simply controlling the mole fraction of PEG-lipid, producing bilayers that exhibit
anomalous behavior similar to biological membranes.
I. INTRODUCTION
Diffusion is an essential transport mechanism in
membrane biology, vital for a wide range of biological
function including protein organization [1], signalling
[2, 3] and cell survival [4]. Interestingly, such living
systems do not in general display the Brownian mo-
tion predicted by a simple random walk model, and
instead exhibit ‘anomalous’ diffusion [5] where the dif-
fusivity is dependent on the timescale of observation.
This phenomenon has been reported both for three-
dimensional diffusion in the cell cytosol [6] and two-
dimensional diffusion in the plasma membrane [7–9].
Here we focus on membrane diffusion.
Why and how anomalous diffusion exists in the
plasma membrane has been the subject of consider-
able investigation (reviewed in [10]). The common
underlying mechanism is thought to be the crowded
environment found in the cell membrane [11], and the
presence of slower-moving obstacles [12, 13], pinning
sites, and compartmentalization [11, 14, 15] have all
been suggested as potential contributors to anoma-
leity in membrane diffusion. Confinement in cellu-
lar membranes is observed on the order of tens to
hundreds of nanometers, with anomalous diffusion re-
ported in a large number of cell types [14, 15]. Overall
this work has led to the adoption of a compartmen-
talized ‘picket fence’ model of the cell membrane as
a proposed improvement to the ‘fluid-mosaic’ model
[11].
Artificial lipid bilayers have played a key role in
improving our understanding of anomalous diffusion
[16–21], where both phase separation [17] and pro-
tein binding [18] in supported lipid bilayers (SLBs)
have been used to generate anomalous diffusion. Sim-
ulations have also been vital in advancing our under-
standing, with much pioneering [5, 22, 23] and recent
[24–29] work in this area. In particular, simulations
have helped elucidate the role of mobile and immobile
obstacles in causing anomalous behavior [12, 13]. Rel-
evant to our work, simulations have also been used to
better interpret single particle tracking data [30] and
provide methods to discriminate between classes of
anomalous diffusion [31].
Despite these advances, the specific molecular
mechanisms that give rise to anomalous diffusion in
vivo remain elusive. This is most clearly highlighted
by Saxton et al., who published a call for ‘a positive
control for anomalous diffusion’ as a solution to this
problem [10]. This positive control would be a sim-
ple and reproducible experimental model exhibiting
‘readily tuneable’ anomalous diffusion spanning sev-
eral orders of magnitude in timescale. Here we seek to
address this call by engineering a simple experimental
model in which it is possible to select the anomalous
behavior. We take advantage of previous work on the
disruption of SLB formation by PEG-DPPE [32] to
control nanoscale obstacle formation in a bilayer (Fig.
1A). By varying the PEG-DPPE composition in a bi-
layer, we expect that an increased fraction of polymer
in the brush regime will result in the formation of
specific defects in the bilayer, similar to interfacial or
grain boundary defects caused by phases separating
mixtures [33]. Similar defects have also been reported
using Atomic Force Microscopy (AFM) of incomplete
SLB formation from small unilamellar vesicles (SUVs)
[34] as well as in SLBs formed in the presence of mem-
brane active peptides [35].
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FIG. 1. PEG bilayer model. (A) Schematic of sup-
ported lipid bilayers. As the mole fraction of PEGylated
lipids increases (left to right), defects form in the bilayer
that that act as obstacles, generating anomalous diffusion.
Representative single-particle tracking of smTIRF (B) and
iSCAT (C) images (scale 10 µm and 1 µm, respectively).
The complex nanometer-scale confinement reported
in cell membranes gives rise to anomalous behav-
ior that spans from microseconds to seconds. Thus
to properly characterize anomalous diffusion, it is
important to apply techniques capable of studying
these timescales. Here we exploit a combination
of single-molecule Total Internal Reflection Fluores-
cence (smTIRF) [36] and Interferometric Scattering
(iSCAT) microscopies [37, 38] (Figs. 1B and C, Sup-
plementary Methods) to characterize diffusion using
single-particle tracking that spans over four orders of
magnitude in time.
II. THEORY
Anomalous diffusion describes random molecular
motion that does not display a linear scaling of the
second moment with time. The most common model
for anomalous diffusion is to allow the second moment
to scale as a power of time [5, 39],〈
∆r2
〉
= 4Γ∆tα, (1)
where α is the anomalous exponent and D is replaced
by Γ, the anomalous transport coefficient. Anomalous
sub- and super-diffusion are defined by α < 1 and α >
1. Given the form of equation 1, α can be determined
from the gradient of a logarithmic plot of
〈
∆r2
〉
/4∆t
vs. ∆t.
The transport coefficient Γ is somewhat more diffi-
cult to interpret as it has dimension of [L]2/[T]α, thus
its dimensions are changing for different degrees of
anomalous behavior. This apparent problem can be
overcome by de-dimensionalizing the observation time
[5] using a ‘jump time’, τ :
〈
∆r2
〉
= 4D∆t
(
∆t
τ
)α−1
. (2)
τ can be interpreted in terms of a length scale (λ)
associated with the anomalous behavior in 2D (λ =√
4Dτ).
III. RESULTS
A. Supported Lipid Bilayers
We produced SUVs from DOPC doped with PEG-
DPPE (0 - 10 mol% PEG-DPPE; 1,2, & 5 kDa PEG-).
Fusion of these SUVs onto a glass coverslip created a
SLB. We confirmed the physical nature of the bilay-
ers using AFM (Fig. 2A): As PEG-DPPE content
increases, small defects appear in the bilayer. Further
increase in the concentration of PEG-DPPE results
in the extension of the interfacial defects, until the
system crosses the percolation threshold. This leads
to confined bilayer patches. Image binarization and
autocorrelation were used to calculate the excluded
area fraction and the length scale associated with the
defects.
The diffusive properties of these bilayers were as-
sessed using single-particle tracking: smTIRF mi-
croscopy was used to follow Texas Red-labelled lipids
(∼ 10−6 mol% TR-DHPE) at 200 Hz; iSCAT
tracked 40 nm antibiotin-conjugated gold nanoparti-
cles (AuNPs) tethered to biotinylated lipids at 5 kHz.
As the concentration of PEG(2K)-DPPE was in-
creased from 0 to 6 mol%, the gradient of the
log
(〈∆r2〉/4∆t) vs. log(∆t) plot deviates from zero
(Fig. 2B). Figure 2C shows the equivalent PEG(2K)-
DPPE dataset arising from iSCAT. Similar plots were
produced for PEG(1K)- and PEG(5K)-DPPE (Fig.
S1). Gradients extracted from these plots (α − 1) al-
low calculation of the anomalous exponent, while the
y-axis intercept reports the transport coefficient. The
values of α for all three PEG molecular weights are
collated in Figure 2D; α transitions from 1 (free dif-
fusion) to 0 (confined diffusion). These data were fit
empirically by a simple sigmoid. The midpoint of each
sigmoid is a measure of the transition between contin-
uous and discontinuous diffusion. Both smTIRF and
iSCAT measurements give rise to the same trend (Ta-
ble S1). Figure 2F shows the equivalent variation of
Γ with mol% PEG-DPPE. Again, in agreement with
Figure 2D, the apparent diffusion coefficient slows as
the particles become confined. It is worth emphasiz-
ing that as Γ scales with α, only points with the same
α values can be compared directly. Limiting values
for Γ differ as expected between smTIRF and iSCAT
experiments due to the size difference of fluorescently
labelled lipids and AuNPs [40].
Using our AFM calibration (Fig. S2), we are able
to convert mol% to excluded area fraction (Fig. 2E).
For both α and Γ, the sigmoids for the three differ-
ent PEG molecular weights now overlap, showing the
same trend with excluded area fraction. For α vs. ex-
cluded area fraction a single sigmoid fit yields a mid-
point at α = 0.232± 0.001.
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FIG. 2. Anomalous diffusion in PEG bilayers. (A) AFM shows an increase in defect area fraction with increasing
mol% PEG-DPPE (scale 500 nm). (B) Anomalous sub-diffusion increases as amount of PEG-DPPE increases from 0
(black) to 10 (yellow) mol%, here for PEG(2K)-DPPE. (C) Equivalent iSCAT data for 0 to 2.6 mol% PEG(2K)-DPPE.
Variation of α and Γ with mol% PEG-DPPE (D&F), and excluded area fractions (E&G). PEG(1K)- (blue triangles),
PEG(2K)- (red circles) and PEG(5K)-DPPE (green squares). Error bars (grey) throughout represent standard errors.
B. Monte Carlo Simulations
To help improve our understanding of these exper-
imental results we constructed a simple Monte-Carlo
simulation of anomalous diffusion: A periodic square
lattice of circular, immobile obstacles of radius R was
simulated using a unit cell with side-length s (Fig.
4A). A discrete-time random walk was subject to the
constraint that the walk cannot enter the circular ob-
stacle. As expected, anomalous behavior arises in the
simulation as the excluded area fraction was increased
(Fig. 4B), and again a plateau of normal diffusion at
short times was observed. When values are collated a
sigmoidal trend was present with α = 0 being reached
near to the percolation threshold for circular obsta-
cles on a square lattice (0.785). Γ was best fit by a
double-sigmoid (Fig. 4D, Table S2).
Combining equations 1 and 2, a linear variation of
log10 (Γ/D) with α is expected; and reproduced by our
data. The characteristic length scales (λ) calculated
from both simulation (Fig. 4E) and experiment (Fig.
4F) are summarized in Table S3.
IV. DISCUSSION
The presence of PEG-DPPE disrupts SLB forma-
tion leaving a network of defects whose area fraction
is dependent on the concentration. We have exploited
this defect formation to create predictable and tune-
able anomalous behavior. It is bilayer continuity (not
the presence of PEG as an obstacle) that causes the
anomalous behavior. Our controls (Fig. S4) confirm
that normal diffusive behavior can be rescued by fill-
ing in bilayer defects.
The variation of α and Γ with excluded area fraction
that we observe shows a sigmoidal transition between
free and confined diffusion. This relationship can be
used to tune anomalous behavior. It has been shown
using simulations [24] and in cell membranes [15, 16,
46–48] that α values of 0.5 to 0.7 are most biologically
relevant. Using our model, we can make specific and
controlled changes to obstacle extent that match this
range; providing an opportunity to use this simple
model to help predict and study biological systems
that exhibit complex membrane diffusion in vivo.
We must also address the limitations of this model
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FIG. 3. Monte Carlo simulations of anomalous diffusion. (A) Schematic of the unit cell. (B) Diffusion analysis
of the resultant tracks showed similar behavior to experiment (R = 500 nm, D = 3 µm2 s−1). (C&D) A similar trend
to experiment was also present for α and Γ for R = 150 nm, 500 nm and 1 µm (grey triangles, black circles, teal squares
respectively). (E) Plots of log10 (Γ/D) vs. α show the expected linear relation, dependent on obstacle size. (F) Similar
plots for our experimental data show an essentially static linear relationship for different PEG lengths. PEG(1K)- (blue
triangles), PEG(2K)- (red circles) and PEG(5K)- (green squares).
system. Confinement in cell membranes is not created
directly by membrane defects, but is likely due to the
excluded area created by membrane proteins and their
interactions with lipids. Despite these fundamental
differences, both result in a similar restriction to free
diffusion in the bilayer, and a parallel can be drawn
between the excluded area controlled in this simple
model and that inaccessible to diffusing species in cell
membranes.
Theory predicts that in a system with finite hier-
archy, the diffusion will return to normal behavior
(with a reduced diffusion coefficient) at sufficiently
long observation times [44]. Figure 2B shows that
over the time scales observed in these experiments,
the diffusion here remains anomalous. As normal be-
havior returns at around 100 ms for similarly sized
compartments in cells [15], our model must not pos-
sess the restricted range of compartment size that are
presumably present in cell membranes. However, we
predict that additional control of bilayer defect for-
mation would enable a return to normal diffusion at
these timescales, for example by nano-patterning of
the substrate before SLB formation [45].
By using two single-particle microscopy techniques
we have sampled the anomalous behavior of this model
over four orders of magnitude of time. Alone, fluo-
rescence microscopy cannot access the divergence of
the diffusivity at short times and the onset of anoma-
lous behavior. However iSCAT is not without its own
limitations: iSCAT image analysis requires efficient
background subtraction [38, 49] which fails if parti-
cles do not move sufficiently e.g. within the confined
regime. The high frame rate of iSCAT also presents
its own challenges in data management, preventing us
from probing all the relevant timescales with a single
technique.
Our simulations helped us to understand the rela-
tionship between α and excluded area fraction. In
the square lattice model, an excluded area fraction of
0.785 represents the point at which the obstacle di-
ameter is equal to the size of the unit cell, s. This is
therefore the point at which confinement occurs. The
mid point of the sigmoidal fit occurs at an excluded
area fraction of 0.773 and the fit effectively reaches α
= 0 at 0.808. If we consider α to sample the probabil-
ity of being confined, we can say that the mid-point
is indicative of the percolation threshold. Using this
to interpret the experimental data we find that the
percolation threshold of our model falls around an ex-
cluded area fraction of 0.232± 0.054.
Perhaps of greatest interest is the difference be-
tween plots of log10(D/Γ) vs. α between our simula-
tions and experiment (Table S3): Only our simulation
shows a variation in length scale with obstacle size. In
contrast, our experimental data shows a similar gra-
dient for all three molecular weights of PEG-DPPE.
This suggests that in the experiment the size (but not
number or extent) of defects produced are of a simi-
lar scale ( 150 nm) and are independent of the PEG
molecular weight. The values extracted from AFM
FWHMs are smaller by around a factor of 3. There
is also a modest negative correlation between FWHM
and excluded area fraction (see Fig. S4). The dif-
ferences between experiment and simulation are most
5likely due to the different topologies for defects in the
two cases: To preserve simplicity, defects in the sim-
ulation were simple circles. This is in contrast to our
experimental AFM images (Fig. 2A) that show not
circular, but rather interfacial defects for intermedi-
ate PEG-lipid concentrations. We therefore interpret
this characteristic length scale as a descriptor of the
barrier to diffusion. In our model, that is the scale
associated with bilayer defects, and in cells it is likely
to be associated with the cytoskeleton.
V. CONCLUSION
By controlling SLB formation using PEGylated
lipids we are able to produce bilayers with defined
anomalous diffusive properties, dependent on the ex-
cluded area fraction. Thus, we hope our work in part
answers the call for a simple and reproducible exper-
imental model, readily tuneable in anomaleity over
the length scales observed in vivo. This study also
opens the way to further experiments that exclude
membrane area using more complex methods than the
simple inclusion of PEG-lipids presented here. Future
work must be directed to expand our understanding of
cell membranes - to recreate biological pathways con-
trolled by diffusion, and to enable the rational design
of devices with tailored bilayer properties.
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I. SUPPLEMENTARY FIGURES
A
C
B
D
FIG. S1.
〈
∆r2
〉
/4∆t vs. ∆t Plots. PEG(1K)-DPPE; (A) fluorescence and (B) iSCAT and PEG(5K)-
DPPE; (C) fluorescence and (D) iSCAT to accompany the PEG(2K)-DPPE data in Fig. 2B/C. The
same behaviour is seen for all three PEG molecular weights. Along with Fig. 2B/C the data from
these plots are used to extract Γ) and α as outlined in the Results section of the main text.
2
FIG. S2. Conversion to excluded area fraction. Image auto-thresholding (see Supplementary
Methods) was used to get an excluded area fraction from the AFM images for several concentrations
of PEG-DPPE. Plotted against mol% PEG-DPPE and fitted with sigmoidal functions, we get a
calibration curve by which to covert mol% PEG-DPPE to excluded area fraction.
A B
FIG. S3. Extended plot of (A) excluded area fraction vs. α and (B) excluded area fraction
vs. Γ. Fig. 2E & 2G show the same data for 0 6 α 6 0.6 to highlight the overlap of sigmoids for the
three datasets. Here, all data is shown (0 6 α 6 1). PEG(1K)-, PEG(2K)- and PEG(5K)-DPPE are
represented in blue triangles, red circles and green squares respectively.
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FIG. S4. Anomalous behaviour is a result of confinement in bilayer patches. (A) single-
particle tracking of anomalous diffusion was repeated on a SLB exhibiting anomalous behaviour
(DOPC; 2.6% PEG(2K)-DPPE). This bilayer was then incubated with DOPC SUVs. The additional
vesicles ruptured within the defects, repaired the bilayer and returned normal diffusive behaviour.
(B) FRAP shows similar behaviour, with 2.6% PEG(2K)-DPPE bilayers exhibiting a large slow and
immobile fraction. Upon addition of DOPC SUVs, diffusion again recovers (D = 1.75 µm2 s−1, mo-
bile fraction 0.99) to values comparable to a pure DOPC bilayer (D = 1.81 µm2 s−1, mobile fraction
1.00).(C) Droplet interface bilayers (DIBs) [? ? ] (Fig. S5) were used to create unsupported lipid
bilayers and confirm PEG-lipids alone do not result in anomalous behaviour. In DIBs, defects would
result in conductance across the bilayer, unstable droplets and ultimately bilayer rupture [? ]. Fol-
lowing our previous methods [? ], ‘lipid-in’ DIBs (2.6 or 5.0 mol% PEG(2K)-DPPE; ∼ 10−6 mol%
TR-DHPE) were formed. Single-particle tracking using TIRF microscopy showed normal diffusion
even for 5.0 mol% PEG-DPPE, well above the threshold value for anomalous behaviour in SLBs.
Bilayers containing 0 (black), 2.6 (red) and 5.0 (yellow) mol% PEG(2K)-DPPE all exhibit normal
diffusion. In Droplet Interface Bilayers (DIBs),
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FIG. S5. Length scales extracted from autocorrelation analysis of the AFM images. There
is a modest decrease in length scale as excluded areas fraction increases. Black data point is DOPC
only SLB. PEG(1K)-, PEG(2K)- and PEG(5K)-DPPE are represented in blue triangles, red circles
and green squares respectively.
PMMA deviceHexadecane
Agarose
DPhPC
Coverslip
PEG-DPPE
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FIG. S6. Schematic of a droplet interface bilayer (DIB). DIBs were prepared following our
previous protocol (Leptihn et al. Nature Protocols 8, 1048, 2013).
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II. SUPPLEMENTARY TABLES
TABLE S1. Experiment sigmoid fit midpoints. Midpoints extracted from the sigmoid fit of the
α vs. mol% PEG-DPPE plots, Fig. 2D, for both fluorescence and iSCAT data. In each case the
midpoint agrees within 6% and can be regarded as an indicator of the percolation threshold.
PEG / kDa mol% (fluorescence) mol% (iSCAT)
1 4.556± 0.004 4.785± 0.053
2 2.700± 0.002 2.545± 0.019
5 1.745± 0.001 1.745± 0.005
TABLE S2. Simulation sigmoid fit midpoints. Midpoints extracted from the sigmoid fit of the
α vs. EAF (Fig. 4C) and Γ vs. EAF (Fig. 4D) plots. Figure 4C was fitted with a single sigmoid,
whereas Figure 4D was better fit by a double sigmoid.
EAF 1 EAF 2
α (Fig. 4C) - 0.773± 0.002
Γ/ µm2 s−α (Fig. 4D) 0.277± 0.001 0.737± 0.001
TABLE S3. Anomalous length scales (λ) for experiment and simulation.
Simulation
R /nm 150 500 1000
λ /nm 65± 3 177± 7 479± 24
Experiment
PEG /kDa 1 2 5
λ /nm 196± 4 145± 2 160± 3
AFM FWHM /nm 54± 8 56± 2 62± 8
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III. SUPPLEMENTARY METHODS
A. Materials
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-diphytanoyl-sn-glycero-3-phosphocholine
(DPhPC) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-cap-biotinyl (biotin-DOPE)
were purchased from Avanti Polar Lipids (Alabaster, AL). Texas Red 1,2-dihexadecanoyl-
sn-glycero-3-phosphoethanolamine (TR-DHPE) triethylammonium salt and 1,2-dipalmitoyl-
sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol) - 1000/2000/5000] am-
monium salt (PEG1/2/5K-DPPE) were purchased from Invitrogen (Eugene, OR). Goat
antibiotin-conjugated 20 nm gold nanoparticles were purchased from BBI (Cardiff, UK). Stan-
dard phosphate-buffered saline tablets (P4417), hexadecane (296317) and silicone oil AR20
(10836) were purchased from Sigma-Aldrich (St-Louis, MO). All chemicals and solvents were
of analytical grade and used without further purification. 18.2 MΩ cm water (Merck Millipore,
Billerica, MA) was used to prepare all solutions.
B. Supported Lipid Bilayers
Glass coverslips (VWR, Menzel Gla¨ser #1) were rigorously cleaned using stepwise sonication
with detergent (Decon-90), water, and propan-2-ol. Immediately before use, the glass was dried
under nitrogen, cleaned with oxygen plasma for 3 minutes (Diener Electronic, Femto), and
stored under water before use. A well was created on each coverslip using vacuum grease (Dow
Corning high vacuum grease). 50 µL of SUV stock was diluted 1:1 in buffer (PBS pH 7.4)
and added to the chamber immediately. The vesicles were incubated for 60 minutes before the
membranes were washed with de-gassed Milli-Q.
SLBs were prepared on glass coverslips by vesicle fusion [? ]. Lipid mixtures (1 mg mL−1
DOPC; ∼ 10−6 mol% each TR-DHPE and biotin-DOPE) were doped with varying amounts of
PEG-lipids to span a range of 0 to 10 mol%. Lipid mixtures were dried under nitrogen and
placed under vacuum overnight. The dried lipids were hydrated in water and votexed before tip
sonication for 15 minutes. The resulting clear, vesicle suspension was centrifuged (3 minutes;
14000g) before the supernatant was separated and retained.
C. Droplet Interface Bilayers
DIBs were prepared following our previous protocol [? ]. Briefly, SUVs of DPhPC only
and DPhPC + PEG(2K)-DPPE were prepared as described above and diluted with buffer to
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a final concentration of 0.5 mg ml−1. 100 nl droplets of SUV solution were pipetted into a
microfabricated tank containing hexadecane and incubated for 40 min. DPhPC (8.9 mg ml−1
in 9:1 hexadecane:silicone oil) was prepared from chloroform stock. A microfabricated PMMA
device containing the agarose layer on a glass coverslip was incubated with the DPhPC in oil
solution for 20 min. Incubated droplets were then added to the device and left for 10 min to
allow bilayer formation before imaging. The DIB experiment is represented schematically in
Figure S6.
D. Atomic Force Microscopy
AFM was carried out using a Bioscope (Bruker, MA). An SNL-10B cantilever was used with
a spring constant of 0.12 N m−1. The instrument was run in peak-force tapping mode with
a maximum applied force of 40 pN. Auto-thresholding was carried out on exported TIFs in
FIJI [? ]. Auto-correlation of the images was performed using the FD Math function. The
resultant plot was then radially averaged using a radial profile. The resultant plot was fitted
with a Lorentzian function to extract the FWHM.
E. Fluorescence Recovery After Photobleaching
Fluorescence recovery after photobleaching (FRAP) experiments were carried out as de-
scribed by Axelrod et al. [? ]. Briefly, an DOPC SLB was made with 0.5 mol% TR-DHPE,
and subjected to intense laser light through a small iris for 5 s. The iris was then opened,
the illumination intensity reduced, and the bilayer was imaged every 5 s for the following 20
min. The result was a video showing the fluorescence slowly recovering in the region where the
intense laser light had caused strong photobleaching. Image analysis of this recovery process
yielded the diffusivity of the TR-DHPE in the SLB. This was quantified by fitting with a mod-
ified Bessel function as outlined by Soumpasis [? ]. This fitting method is only applicable to
bilayers exhibiting normal diffusion and as such, the bilayer containing PEG(2K)-DPPE at 2.6
mol% was not quantified.
F. Total Internal Reflection Fluorescence Microscopy
A 532 nm continuous-wave laser was launched into an inverted microscope (Eclipse TiE;
Nikon) and focussed at the back aperture of the objective lens (60× TIRF oil-immersion NA
1.49, Nikon, ∼1.4 kW cm−2 at the sample) such that total internal reflection occurred. The re-
sultant fluorescence signal was transmitted through dichroic (ZT532rdc) and bandpass (605/55)
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filters (both Chroma, Bellows Falls, VT) before being imaged onto an electron-multiplying CCD
(iXon+ 860; Andor) at 200 Hz.
G. Interferometric Scattering Microscopy
A custom-built microscope was built to conduct these measurements as described [? ? ].
Briefly, a 639 nm laser beam (Toptica, Graefelfing, Munich) was directed through a polarizing
beam splitter and quarter wave plate (both Thorlabs, Newton, NJ) before reaching a focus at the
back aperture of an objective lens (100× oil immersion NA 1.49 Nikon). Light scattered from the
coverslip interface and the object of interest, produce an interference pattern, which is returned
through the beam splitter. The resultant signal was then magnified (overall magnification
174×) and imaged onto a CMOS camera (Phantom Miro 340). To track AuNP-labelled lipids,
a SLB was formed as described above and 5 µL of anti-biotin OD10 40 nm gold nanoparticles
were added. After 2 hours incubation, the SLB was washed thoroughly with buffer to remove
unbound nanoparticles before imaging. Image stacks of 10000 frames were recorded at 100 kHz.
Image stacks were then temporally-averaged to 5 kHz before tracking tracking.
H. Single-Particle Tracking
The movement of fluorescent lipids between frames of the recorded videos was tracked using
the TrackMate plugin for ImageJ [? ]. Briefly, spots were detected in each frame using a
Laplacian of Gaussian (LoG) filter. Tracks were then generated by linking these detected spots
together using a simple linear assignment problem (LAP) tracker. The output from this was a
collection of tracks containing the space-time co-ordinates of each point in the track. This data
was subsequently used to obtain mean-squared displacements for different observation times,
which in turn was used to obtain diffusivity values via the random walk model of diffusion.
I. Monte Carlo Simulations
For each of 200 simulated particles, two separate random walks were created (corresponding
to the displacement in x and y coordinates) using a pseudorandom number generator (Mersenne
Twister). In order to account for the presence of obstacles to diffusion, periodic boundary
conditions were used. The unit cell of the simulation is shown in Figure 4A of the main
text. With each step of the random walk, the new coordinates were tested to see if they were
inside an obstacle or not. If they were, then that step was rejected, and a new one generated.
The resulting sets of co-ordinates for each simulated particle were subsequently processed in
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the same way as experimental data obtained from tracking labelled particles. These tracks
represent diffusing particles that have been hindered due to the presence of obstacles, and
exhibited anomalous diffusion as expected.
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